US 10729781
LGR4 specific monoclonal antibodies and methods of their use
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 10729781 (LGR4 specific monoclonal antibodies and methods of their use) held by The Board of Regents of the University of Texas System expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K47/68031, A61K47/6849